BRIEF-Q32 Bio Inc To Discontinue Renal Basket Trial For Adx-097 To Conserve Resources

Reuters
11 Feb
BRIEF-Q32 Bio Inc To Discontinue Renal Basket Trial For Adx-097 To Conserve Resources

Q32 Bio Inc QTTB.O:

  • Q32 BIO INC: TO DISCONTINUE RENAL BASKET TRIAL FOR ADX-097 TO CONSERVE RESOURCES

  • Q32 BIO INC: EVALUATE STRATEGIC OPTIONS FOR ITS TISSUE-TARGETED COMPLEMENT INHIBITOR PLATFORM

  • Q32 BIO INC: CASH RUNWAY EXPECTED TO EXTEND TO 2H'26

  • Q32 BIO INC: INITIATING OPEN-LABEL EXTENSION FROM SIGNAL-AA PART A IN 1H'25

  • Q32 BIO INC: SIGNAL-AA PART B REMAINS ON TRACK FOR INITIATION OF DOSING IN 1H'25, WITH TOPLINE DATA EXPECTED IN 1H'26

Source text: ID:nPn11yPfKa

Further company coverage: QTTB.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10